Posts

Showing posts with the label peripheral neuropathy

ineffectiveness of gabapentinoids for pain or radiculopathy

Image
  there has been a major increase in prescribing gabapentinoids (gabapentin and pregabalin) for chronic pain and neuropathic pain, despite many studies finding no or minimal effect. there is an impressive list of associated adverse events including very serious ones, however.     -- a study done on gabapentinoid utilization in 72 countries from 2012 o 2023 found annual sale increase by 114.5% from 2012 to 2022, with a 180.9% increase in developing countries and a 110.0% increase in developed countries: see graph below from gabapentinoid and opiate utilization 2012 to 2023 Pharmicoepidem2025 in dropbox, or doi.org/10.1002/pds.70149     -- gabapentinoids, however, have substantial side effects like dizziness, somnolence, and gait disturbance, with the number of patients needed to take gabapentinoids in order for one of them to experience adverse effects ranging from 3 to 11 depending on the adverse effect, with approximately 33% of patients experiencing somnolen...

nocturnal leg cramps: vitamin K2 helps

Image
  A recent study found that vitamin K2 decreased nocturnal leg cramps in older patients (see   nocturnal cramps vit K2 helps JAMAintmed2024  in dropbox, or doi:10.1001/jamainternmed.2024.5726)   Details: --199 community-dwelling individuals 65 years and older participated in this multicenter, double-blind, placebo-controlled randomized clinical trial conducted in China between September 2022 and December 2023     -- all had 2 or more documented episodes of nocturnal leg cramps (NLCs) during 2 weeks of screening -- 103 participants were randomly assigned to 180 μg vitamin K2 (menaquinone 7) capsules or a similar-looking placebo every day for 8 weeks, 96 patients were randomized to placebo -- 108 (54%) were female, mean age 72 years -- hypertension 68%, diabetes 51%, serum creatinine 0.89 mg/dL -- baseline weekly frequency of cramps was 2.60 in the vitamin K2 group and 2.71 in the placebo group -- patients with other relevant conditions (r...